Bioharvest sciences reports second quarter 2025 financial results

Robust 41% year-over-year revenue growth, driven by strong core capsule and new product sales rehovot, israel--(newsfile corp. - august 11, 2025) - bioharvest sciences inc. (nasdaq: bhst) (fse: 8mv0) ("bioharvest" or the "company"), a company pioneering its patented botanical synthesis technology platform, today reported its financial and operational results for the second quarter ended june 30, 2025. second quarter 2025 highlights all figures stated in this news release are in u.s. dollars unless stated otherwise.
BHST Ratings Summary
BHST Quant Ranking